Spotlight Therapeutics

Spotlight Therapeutics is a biotechnology company therapeutics targeting CRISPR-validated indications and I-O applications focused on reprogramming the tumor microenvironment. It builds a technology platform to edit the genes in targeted disease organs thereby inactivating or altering the gene product. The company has expertise in preclinical development ranging from protein engineering, gene editing to immuno-oncology, and in vivo safety studies.